Skip navigation

Navigate Compliance, Technology and Supply Logistics to Enable Virtual/Hybrid Trials

August 8-9, 2019
  • Philadelphia, PA

The Direct-to-Patient (DtP) clinical trial model benefits both patients and industry by making participation more convenient while improving patient recruitment, retention and adherence. However, a DtP/virtual trial presents a unique set of challenges that must be considered before adopting this new model. CBI’s 2nd Annual Direct-to-Patient Clinical Trials brings together industry leaders in clinical innovation to help you work through the biggest hurdles in operationalization, technology use and data management, and global compliance amongst other topics that are key to enabling a virtual or hybrid trial.

COLLABORATE WITH KEY THOUGHTLEADERS ON STRATEGIES TO ADDRESS YOUR BIGGEST CHALLENGES:

  • Analyze real-world successes and challenges in DtP trials via case studies
  • Consider when a virtual or hybrid model is appropriate for your trial and how to develop protocol accordingly
  • Examine how to successfully operationalize a DtP trial
  • Break down global, regional, and local regulations regarding drug distribution
  • Consider patient privacy laws, verify patient identity and ensure compliance
  • Investigate novel technologies and tools to improve trial participation and outcomes
  • Harmonize data across all clinical trial systems and streamline data collection
  • Improve system interoperability and flexibility
  • Tackle global supply chain challenges

Download the Conference Preview

Previous Attendee Acclaim:

Great compilation of topics and speakers; discussions were helpful and insightful. Provided a wealth of information to consider as we delve into this area and set our organization up for success

Executive Director of Business Operations & Portfolio Analytics Development,Astellas Pharma

Direct-to-Patient Clinical Trials

Navigate Compliance, Technology and Supply Logistics to Enable Virtual/Hybrid Trials

The Direct-to-Patient (DtP) clinical trial model benefits both patients and industry by making participation more convenient while improving patient recruitment, retention and adherence. However, a DtP/virtual trial presents a unique set of challenges that must be considered before adopting this new model. CBI’s 2nd Annual Direct-to-Patient Clinical Trials brings together industry leaders in clinical innovation to help you work through the biggest hurdles in operationalization, technology use and data management, and global compliance amongst other topics that are key to enabling a virtual or hybrid trial.

COLLABORATE WITH KEY THOUGHTLEADERS ON STRATEGIES TO ADDRESS YOUR BIGGEST CHALLENGES:

  • Analyze real-world successes and challenges in DtP trials via case studies
  • Consider when a virtual or hybrid model is appropriate for your trial and how to develop protocol accordingly
  • Examine how to successfully operationalize a DtP trial
  • Break down global, regional, and local regulations regarding drug distribution
  • Consider patient privacy laws, verify patient identity and ensure compliance
  • Investigate novel technologies and tools to improve trial participation and outcomes
  • Harmonize data across all clinical trial systems and streamline data collection
  • Improve system interoperability and flexibility
  • Tackle global supply chain challenges

Download the Conference Preview

Previous Attendee Acclaim:

Great compilation of topics and speakers; discussions were helpful and insightful. Provided a wealth of information to consider as we delve into this area and set our organization up for success

Executive Director of Business Operations & Portfolio Analytics Development,Astellas Pharma